These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17439758

  • 1. Invasive breast cancer.
    Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Ljung BM, Kiel K, Marks LB, McCormick B, Nabell LM, Pierce LJ, Reed EC, Silver SM, Smith ML, Somlo G, Theriault RL, Ward JH, Winer EP, Wolff AC.
    J Natl Compr Canc Netw; 2007 Mar; 5(3):246-312. PubMed ID: 17439758
    [No Abstract] [Full Text] [Related]

  • 2. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ.
    Cancer; 2005 Jun 15; 103(12):2447-54. PubMed ID: 15887223
    [Abstract] [Full Text] [Related]

  • 3. [1st revision of the National Consensus on Breast Cancer Treatment].
    Consenso Nacional sobre Tratamiento del Cáncer Mamario.
    Ginecol Obstet Mex; 2002 Jul 15; 70():349-60. PubMed ID: 12221911
    [No Abstract] [Full Text] [Related]

  • 4. ABC of breast diseases: breast cancer.
    Sainsbury JR, Anderson TJ, Morgan DA.
    BMJ; 2000 Sep 23; 321(7263):745-50. PubMed ID: 10999911
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of screening on clinicopathological features and treatment for invasive breast cancer: results of two national surveys.
    Cutuli B, Dalenc F, Cottu PH, Gligorov J, Guastalla JP, Petit T, Amrate A.
    Cancer Radiother; 2015 Aug 23; 19(5):295-302. PubMed ID: 26188735
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neoadjuvant chemotherapy in breast cancers.
    Masood S.
    Womens Health (Lond); 2016 Sep 23; 12(5):480-491. PubMed ID: 27885165
    [Abstract] [Full Text] [Related]

  • 9. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S, Hui JYC, Huang JL, Kizy S, Beckwith H, Blaes AH, Rueth NM, Tuttle TM.
    Cancer; 2017 Aug 15; 123(16):3015-3021. PubMed ID: 28382636
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Christchurch Breast Cancer Patient Register: the first year.
    Davey V, Robinson B, Dijkstra B, Harris G.
    N Z Med J; 2012 Aug 24; 125(1360):37-47. PubMed ID: 22932653
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres.
    Angarita FA, Chesney T, Elser C, Mulligan AM, McCready DR, Escallon J.
    Eur J Surg Oncol; 2015 May 24; 41(5):625-34. PubMed ID: 25727372
    [Abstract] [Full Text] [Related]

  • 14. Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma.
    Gultekin M, Yazici O, Eren G, Yuce D, Aksoy S, Ozisik Y, Guler N, Yazici G, Hurmuz P, Yildiz F, Altundag K, Gurkaynak M.
    Breast; 2014 Dec 24; 23(6):775-83. PubMed ID: 25201554
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E, Győrffy B, Kásler M, Mátrai Z.
    Eur J Surg Oncol; 2017 Apr 24; 43(4):672-679. PubMed ID: 28139362
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
    Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG.
    J Clin Oncol; 2008 May 01; 26(13):2093-8. PubMed ID: 18445838
    [Abstract] [Full Text] [Related]

  • 19. 8. The dilemma of in situ carcinoma of the breast.
    Fentiman IS.
    Int J Clin Pract; 2001 Dec 01; 55(10):680-3. PubMed ID: 11777293
    [Abstract] [Full Text] [Related]

  • 20. Tubular carcinoma of the breast: institutional and SEER database analysis supporting a unique classification.
    Romano AM, Wages NA, Smolkin M, Fortune KL, Atkins K, Dillon PM.
    Breast Dis; 2015 Dec 01; 35(2):103-11. PubMed ID: 25567000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.